Better Buy for 2021: Pfizer or Gilead?

Motley Fool2021-04-05

In a post-pandemic world, one company has the lower valuation and higher dividend yield to be a success. The performance of most pharmaceutical stocks has been underwhelming over the past year. The ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
20